FilingReader Intelligence
Sunflower Pharmaceutical sets "Hundred Billion" five-year target
August 12, 2025 at 05:20 PM UTC•By FilingReader AI
Sunflower Pharmaceutical Group approved its 2026-2030 development plan targeting "Hundred Billion Sunflower" growth.
However, the company determined that conditions for unlocking the third period of its 2022 employee stock ownership plan were not met, indicating performance targets were missed.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
SZSE:002737•Shenzhen Stock Exchange
News Alerts
Get instant email alerts when Sunflower Pharmaceutical Group publishes news
Free account required • Unsubscribe anytime